Carolina Terragna
- Hematology top 0.5%
- Molecular Biology top 10%
- Oncology top 5%
- Genetics top 2%
- Immunology top 10%
- Co-authors
- Michèle CavoElena ZamagniS TuraMichele BaccaraniGiovanni MartinelliPaola TacchettiNicoletta TestoniPatrizia Tosi
- Topics
- Multiple Myeloma Research and Treatments (51 papers)Chronic Myeloid Leukemia Treatments (29 papers)Protein Degradation and Inhibitors (25 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- ItalyUnited StatesGreece
In The Last Decade
Carolina Terragna
96 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 77
- Hematology 1.8k
- Molecular Biology 1.2k
- Oncology 885
- Genetics 354
- Immunology 311
Countries citing papers authored by Carolina Terragna
This map shows the geographic impact of Carolina Terragna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolina Terragna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolina Terragna more than expected).
Fields of papers citing papers by Carolina Terragna
This network shows the impact of papers produced by Carolina Terragna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolina Terragna. The network helps show where Carolina Terragna may publish in the future.
Co-authorship network of co-authors of Carolina Terragna
This figure shows the co-authorship network connecting the top 25 collaborators of Carolina Terragna. A scholar is included among the top collaborators of Carolina Terragna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolina Terragna. Carolina Terragna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 24 | |
| 4 | 5 | |
| 5 | 49 | |
| 6 | 22 | |
| 7 | 40 | |
| 8 | 107 | |
| 9 | 4 | |
| 10 | 7 | |
| 11 | 1 | |
| 12 | 38 | |
| 13 | 1 | |
| 14 | 3 | |
| 15 | 14 | |
| 16 | 41 | |
| 17 | Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia. | 36 |
| 18 | Real-time quantification of different types of BcrAbl transcript in chronic myeloid leukemia | 16 |
| 19 | 20 | |
| 20 | 52 |
About Carolina Terragna
Carolina Terragna is a scholar working on Hematology, Genetics and Oncology, having authored 99 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (51 papers), Chronic Myeloid Leukemia Treatments (29 papers) and Protein Degradation and Inhibitors (25 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (354 citations) and Oncology (885 citations). Carolina Terragna has collaborated with scholars based in Italy, United States and Greece. Frequent co-authors include Michèle Cavo, Elena Zamagni, S Tura, Michele Baccarani, Giovanni Martinelli, Paola Tacchetti, Nicoletta Testoni, Patrizia Tosi, Giulia Perrone and Annamaria Brioli. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.